US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Guided Therapeutics, Inc.

0.2500

0.0000

Volume:2.00

Turnover:0.43

Market Cap:20.90M

PE:-0.87

High:0.2500

Open:0.2500

Low:0.2500

Close:0.2500

52wk High:0.3220

52wk Low:0.0644

Shares:83.60M

Float Shares:27.93M

Volume Ratio:0.00

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2881

EPS(LYR):-0.0372

ROE:43.94%

ROA:-127.56%

PB:-2.88

PE(LYR):-6.71

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Guided Therapeutics Secures $200,000 Initial Order from Yuanshuo Medical Instruments

Director James Michael C Reports Acquisition of Common Shares in Guided Therapeutics Inc

Guided Therapeutics Secures $700K Deal with Chinese Partner for Cervical Cancer Screening Products

Guided Therapeutics Inc. Completes Enrollment for US FDA Clinical Trial of LuViva Cervical Scan Device, Begins Data Analysis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GTHP"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GTHP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GTHP\",,,,,undefined,":{"symbol":"GTHP","market":"US","secType":"STK","nameCN":"Guided Therapeutics, Inc.","latestPrice":0.25,"timestamp":1764965392322,"preClose":0.25,"halted":0,"volume":2,"delay":15,"floatShares":27930093,"shares":83599156,"eps":-0.288051,"marketStatus":"Market Closed","change":0,"latestTime":"12-05 15:09:52 EST Delay","open":0.25,"high":0.25,"low":0.25,"amount":0.42807,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.288051,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.25,"volumeRatio":0.000897988542034379},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GTHP\",,,,,undefined,":{"symbol":"GTHP","floatShares":27930093,"roa":"-127.56%","roe":"43.94%","lyrEps":-0.037243,"volumeRatio":0.000897988542034379,"shares":83599156,"dividePrice":0,"high":0.25,"amplitude":0,"preClose":0.25,"low":0.25,"week52Low":0.0644,"pbRate":"-2.88","psRate":"117.41","week52High":0.322,"institutionHeld":0,"latestPrice":0.25,"eps":-0.288051,"divideRate":0,"volume":2,"delay":15,"ttmEps":-0.288051,"open":0.25,"prevYearClose":0.15,"prevWeekClose":0.25,"prevMonthClose":0.25,"prevQuarterClose":0.24,"fiveDayClose":0.25,"twentyDayClose":0.25,"sixtyDayClose":0.2795},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GTHP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-14","symbol":"GTHP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-14","symbol":"GTHP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-13","symbol":"GTHP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-28","symbol":"GTHP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-13","symbol":"GTHP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699851600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GTHP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GTHP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GTHP\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584944023","title":"Guided Therapeutics Secures $200,000 Initial Order from Yuanshuo Medical Instruments","url":"https://stock-news.laohu8.com/highlight/detail?id=2584944023","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584944023?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:00","pubTimestamp":1763560853,"startTime":"0","endTime":"0","summary":"Guided Therapeutics Inc. has announced the completion of an initial supply agreement with Yuanshuo Medical Instruments Corporation , based in Jiangsu province, China. Under the agreement, YMIC will purchase $200,000 worth of LuViva Advanced Cervical Scan devices and single-use components. Additional orders are anticipated next year as part of a broader supply agreement currently under discussion. This new agreement is in addition to an existing arrangement with Hangzhou Dongye Medical Technology Company, Ltd.  for the supply of 35 devices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guided Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on November 19, 2025, and is solely responsi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL837Vdb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GTHP"],"gpt_icon":0},{"id":"2565665564","title":"Director James Michael C Reports Acquisition of Common Shares in Guided Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2565665564","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565665564?lang=en_us&edition=fundamental","pubTime":"2025-09-05 23:51","pubTimestamp":1757087472,"startTime":"0","endTime":"0","summary":"James Michael C, a Director of Guided Therapeutics Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guided Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nNDL2ySFMD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director James Michael C Reports Acquisition of Common Shares in Guided Therapeutics Inc","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GTHP"],"gpt_icon":0},{"id":"2560346194","title":"Guided Therapeutics Secures $700K Deal with Chinese Partner for Cervical Cancer Screening Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2560346194","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560346194?lang=en_us&edition=fundamental","pubTime":"2025-08-19 21:01","pubTimestamp":1755608484,"startTime":"0","endTime":"0","summary":"Guided Therapeutics Inc. has announced a new contract with Hangzhou Dongye Medical Technology Company, Ltd.  in China. The agreement involves a series of nine payments totaling $700,000 for the LuViva Advanced Cervical Scan components and services. So far, Guided Therapeutics has received $100,000, including a recent $70,000 payment which triggers the shipment of three sets of components to HDMT and the manufacture of four additional sets. Once these are assembled and tested, it will initiate the next payment of $80,000. HDMT, based in Hangzhou City, is the exclusive provider of gynecology products for 42 hospitals, conducting approximately two million cervical cancer screenings annually.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nNDL30NF6Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTHP","BK4082"],"gpt_icon":0},{"id":"2559602099","title":"Guided Therapeutics Inc. Completes Enrollment for US FDA Clinical Trial of LuViva Cervical Scan Device, Begins Data Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2559602099","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559602099?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:02","pubTimestamp":1755090138,"startTime":"0","endTime":"0","summary":"Guided Therapeutics Inc. has announced the completion of patient enrollment for its clinical trial involving the LuViva Advanced Cervical Scan, a device designed for the rapid and painless detection of cervical cancer using patented biophotonic technology. The study, which was conducted across four clinical sites, enrolled approximately 430 patients, meeting the company's primary objective for 2025. The data analysis phase is now underway and includes an external review of biopsy samples, data entry from study case report forms, and statistical analysis as per the study protocol. The company anticipates filing the clinical report with the FDA later this year. The trial reported no adverse events linked to the use of LuViva, supporting its designation as a non-significant risk device by the FDA. Results from the statistical analyses are expected to be presented in the future.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL3qJ50z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTHP","BK4082"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GTHP\",params:#limit:6,delay:false,,,undefined,":[]}}